Nitsan Halevy

Dr. Halevy joined Pluristem in 2021 and serves as Chief Medical Officer. She is responsible for clinical development, clinical operations, pharmacovigilance and regulatory affairs. Dr. Halevy has 15 years of experience leading all aspects of clinical development in industry and academic settings. Prior to joining Pluristem, Dr. Halevy held the position of Chief Development Officer in Quark Pharmaceuticals. Earlier in her career, Dr. Halevy held roles of increasing responsibility and scope in clinical research, drug development and medical affairs at Teva, Novartis, and also at Brigham and Women’s Hospital. Dr. Halevy holds an MD from the Joyce and Irving Goldman Medical School at Ben-Gurion University in Be’er Sheva and completed her internship at Sapir Medical Center in Kfar Saba.